Publications
- Richter transformation of chronic lymphocytic leukaemia in the era of treatment with B-cell signalling pathway inhibitors2020 | First Faculty of Medicine
- Prospective observational study in comorbid patients with chronic lymphocytic leukemia receiving first-line bendamustine with rituximab2019 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Treatment of relapsed chronic lymphocytic leukemia2019 | First Faculty of Medicine
- Small Molecules in the Treatment of Chronic Lymphocytic Leukemia in 2015 and in the Near Future2015 | First Faculty of Medicine
- Chronic lymphocytic leukaemia2013 | First Faculty of Medicine
- Minimal residual disease in chronic lymphocytic leukemia: Detection methods and clinical significance2010 | Third Faculty of Medicine
- Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group2023 | Faculty of Medicine in Pilsen, Central Library of Charles University, Faculty of Medicine in Hradec Králové
- Managing BTK inhibitor treatment-related adverse events in patients with chronic lymphocytic leukaemia - cardiovascular complications and bleeding2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Other malignancies in the history of CLL: an international multicenter study coducted by ERIC, the European Research Initiative on CLL, in HARMONY2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
Loading network view...